Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer

Anticancer Research

Volumn 19, Issue 6 C, 1999, Pages 5635-5640

  Ishikawa, Yoichiro ^a   Kubota, Tetsuro ^a   Otani, Yoshihide ^a   Watanabe, Masahiko ^a   Teramoto, Tatsuo ^a   Kumai, Koichiro ^a   Takechi, Teiji ^b   Okabe, Hiroyuki ^b   Fukushima, Masakazu ^b   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Dihydropyrimidine dehydrogenase levels; Gastric cancer; Survival outcome; Thymidylate synthetase levels

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GASTROSCOPY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH MUCOSA;

AGED; DEMOGRAPHY; DIHYDROURACIL DEHYDROGENASE (NADP); FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); OXIDOREDUCTASES; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; THYMIDYLATE SYNTHASE;

EID: 0033367361     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Macdonald JS and Gohmann JJ: Chemotherapy of advanced gastric Cancer: present status, future prospects. Semin Oncol 15 (suppl. 4): 42-49, 1988.
2. Santi DV, Danenberg PV: Folates in pyrimidine nucleotide biosynthesis. New York: Wiley-Liss, Incr, 1984, pp 345-398.
3. Heiderberger C: Fluorinated pyrimidine and their nucleotides. In: Handbook of experimental pharmacology. (Sartorelli AC, Johns DG, eds). New York: Springer-Verlag, 1975, 38: pp 193-231.
4. Langenbach RJ, Danenbergh PV and Heidelbergerr C: Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2′-deoxyuridylate. Biochem Biophys Res Commun 48: 1565-1571, 1972.
5. Peters GJ, van der Wilt CL, van Groeningen CJ, Smid K, Meijer S and Pinedo HM: Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J Clin Oncol 12: 2035- 2042, 1994.
6. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA and Allegra CJ: The role of thymidylate synthase expression in prognosis and outcome of adiuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12: 2640-2647, 1994.
7. Johnston PG, Lenz H-J, Leichman CG, Danenberg KD, Allegra CJ: Danenberg PV and Leichman L: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1412, 1995.
8. Lenz H-J, Leichman CG, Danenberg KD, Danenherg PV, Groshen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Garcia Y, Li J and Leichman L: Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol 14: 176-182, 1995.
9. Leichman CG, Lenz H-J, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M and Danenberg PV: Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted- infusion fluorouracil and weekly leucovorin. J Clin Oncol 15: 3223-3229, 1997.
10. Yamachika T, Nakanishiy H, Inada K, Takamoto T, Kato T, Fukushima M, Inoue M and Tatematsu M: A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer 82: 70-77, 1998.
11. Kuniyasu T, Makamuraf T, Tabuchi Y and Kuroda Y: Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody. Cancer 83: 1300-1306, 1998.
12. Naguib FNM, el Kouni MH and Cha S: Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45: 5405-5412, 1985.
13. McLeod HL, Sludden J, Murray GI, Keenan RA, Davidson AI, Park KJ, Koruth M and Cassidy J: Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer 77: 461-465, 1988.
14. Beck A, Etienne MC, Cheradame S, Fischel JL, Formento P, Reneef N and Milano G: A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur J Cancer 30A: 1517-1522, 1994.
15. Etienne MC, Cheradame S, Fischel JL, Formento P, Dassonville O, Renee N, Schneider M, Thyss A, Demard F and Milano G: Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J Clinf Oncol 13: 1663-1670, 1995.
16. Jiang W, Lu Z, He Y and Diasio RB: Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy. Clin Cancer Res 3: 395-399, 1997.
17. Ishikawar Y, Kubotaf T, Otani, Y, Watanabe M4, Teramoto T, Kumai K, Kitajima M, Takechi T, Okabe H and Fukushima M: Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice. Clinf Cancer Res 5: 883-889, 1999.
18. Ishikawaf Y, Kubotar T, Watanabe M, Kitajimaf M, Takechi T, Okabe H and Fukushima M: Dihydropyrimidine dehydrogenase and its mRNA will be related to the chemosensitivity of human gastric cancer to 5-fluorouracil. Proc Am Assoc Cancer Res 40: 399, 1999.
19. Japanese Research Society for Gastric Cancer. "The General Rules for Gastric Cancer Study 12th Ed." Kanehara Shuppan, Tokyo, 1993 (in Japanese)
20. Spears CP, Shahinian AH, Morank RG, Heidelberger C and Corbett TH: In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and - resistant murine colon adenocarcinomas. Cancer Res 42: 450-456, 1982.
21. Takechi T, Uchida J, Fujioka A and Fukushima M: Enhancing 5-fluorouracil cytotoxicity by inhibiting dihydropyrimidine dehydrogenase activity with uracil in human tumor cells. Int J Oncol 11: 1041-1044, 1997.
22. Ikenaka K, Shirasaka T, Kitano S and Fujii S: Effect of uracil on metabolism of 5-fluorouracil in vitro. Gann 70: 353-359, 1979.
23. Fujita K, Kubota T, Matsuzaki SW, Otani Y, Watanabe M, Teramoto T, Kumai K and Kitjima M: Further evidence for the value of the chemosensitivity test in deciding appropriate chemotherapy for advanced gastric cancer. Anticancer Res 18: 1973-1978, 1998.